You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Finland

May 2012

Price: US$2,400

About this Report

EXECUTIVE SUMMARY

Healthy growth in first half of 2011, replaced by consumer scepticism

Consumer health products in Finland grew healthily in early 2011, witnessing a recovery following the economic downturn in 2009 and early 2010. However, the economic turbulence in the second half of 2011 made consumers more negative and thus also more cautious regarding purchases of unnecessary and premium consumer health products. Sales of private label products and generics accelerated towards the end of 2011 as a result.

Liberalisation and switches boost sales in 2011

Liberalisation of sales with, for example, Internet sales of OTC medicines being made possible as well as several switches all boosted sales in 2011. The most dynamic category was proton pump inhibitors, which were switched to OTC status in 2009 and subsequently saw several new launches in 2010 and 2011, which strongly boosted sales in the latter year, and added value to the overall consumer health market.

Domestic Orion Oyj leads by quite some distance

Finnish Orion Oyj led consumer healthcare in Finland in 2011 accounting for a value share of 15%. It was some way ahead of the closest competitor, Janssen-Cilag Oy, on 9%. The company’s share declined slightly over the review period, due mainly to increasing competition from cheaper generic products. However, the company’s strength is due to its longstanding presence on the Finnish market and well-known brands, including the leading analgesic, Burana, which is the most popular consumer healthcare brand in Finland. The company not only has a wide brand portfolio, being present in most OTC categories, its brands are also strong and often lead sales in the categories in which they are present.

Internet sales jump in 2011 as legislation liberalised

The chemists/pharmacies channel is most important for distribution of consumer health products in Finland. However, this channel steadily lost share throughout the review period. Most recently sales moved towards Internet retailing after legislation was changed to allow pharmacies to sell OTC medicines via the Internet in 2011. In 2006 NRT smoking cessation aids were made available through the grocery channel, which resulted in strongly declining sales through chemists/pharmacies. By 2011 well over half of all NRT smoking cessation aids were sold in the grocery channel. Other categories that are growing in popularity in the grocery channel include vitamins and dietary supplements, sports nutrition, wound care and weight management. Consumers find it convenient to shop for their healthcare products while grocery shopping.

Market maturity and economic downturn threaten growth rates

The consumer healthcare market is mature and price competition is increasing given the growing presence of generics and consumers’ growing trust in these products. Add to this the economic turbulence that started in mid-2011, which is predicted to affect the short-term future, and the forecast period looks slightly bleak. The forecast period constant value CAGR is set to be notably lower than the corresponding figure seen over the review period . However, sales will increase despite the negative aspects, as the population is ageing and birth rates rising. Other factors that will underpin growth include growing obesity levels pushing demand for product categories such as digestive remedies, weight management, sports nutrition, dietary supplements, etc.


Samples (FAQs about samples):

doc_pdf.png Sample Consumer Health Market Research Report

doc_excel_table.png Sample Consumer Health Data

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Finland with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Finland, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Finland for free:

The Consumer Health in Finland market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Finland?
  • What are the major brands in Finland?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Table of Contents

Table of Contents

Consumer Health in Finland - Industry Overview

EXECUTIVE SUMMARY

Healthy growth in first half of 2011, replaced by consumer scepticism

Liberalisation and switches boost sales in 2011

Domestic Orion Oyj leads by quite some distance

Internet sales jump in 2011 as legislation liberalised

Market maturity and economic downturn threaten growth rates

KEY TRENDS AND DEVELOPMENTS

Economic fluctuations

Finland in the midst of demographic changes

VDS mature – and competition is increasing

Health and wellness trend boosted by growing weight problems in Finland

OTC medicines available via Internet

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2006-2011
  • Table 2 Life Expectancy at Birth 2006-2011

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2006-2011
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2006-2011
  • Table 5 Consumer Health Company Shares 2007-2011
  • Table 6 Consumer Health Brand Shares 2008-2011
  • Table 7 Penetration of Private Label by Category 2006-2011
  • Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
  • Table 9 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
  • Table 10 Forecast Sales of Consumer Health by Category: Value 2011-2016
  • Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016

APPENDIX

OTC registration and classification

Vitamins and dietary supplements’ registration and classification

Self-medication/self-care and preventative medicine

Switches

  • Summary 1 OTC-Switches 2009-2011

DEFINITIONS

SOURCES

  • Summary 2 Research Sources

Consumer Health in Finland - Company Profiles

Leiras Finland Oy Ab in Consumer Health (Finland)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 5 Leiras Finland Oy Ab: Competitive Position 2011

Orion Oyj in Consumer Health (Finland)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 8 Orion Oyj: Competitive Position 2011

Suomen Bioteekki Oy in Consumer Health (Finland)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 11 Suomen Bioteekki Oy: Competitive Position 2011

Valioravinto Oy Ab in Consumer Health (Finland)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 14 Valioravinto Oy Ab: Competitive Position 2011

Vitabalans Oy in Consumer Health (Finland)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 17 Vitabalans Oy: Competitive Position 2011

Adult Mouth Care in Finland - Category Analysis

HEADLINES

TRENDS

  • Adult mouth care increased by 2% in current value terms in 2011. Much of the increase in 2011 was a result of increased VAT on medicines from 8% to 9% in July 2010.

SWITCHES

COMPETITIVE LANDSCAPE

  • GlaxoSmithKline dominated adult mouth care with a 68% value share in 2011, due to its well-known Corsodyl brand. The brand has a strong image, and has become popular over the years through advertising campaigns.

PROSPECTS

  • Adult mouth care is predicted to see a marginal constant value CAGR over the forecast period. Growth rates will remain low, hindered by maturity, little activity from manufacturers and competition from standard oral care products. Due to the less positive economic outlook, the forecast constant value growth has been revised downwards slightly compared with last year’s report. Nonetheless, the development will be slightly stronger than seen over the review period. Increasing health and wellness concerns, as well as the ageing population, will help increase sales.

CATEGORY DATA

  • Table 12 Sales of Adult Mouth Care: Value 2006-2011
  • Table 13 Sales of Adult Mouth Care: % Value Growth 2006-2011
  • Table 14 Adult Mouth Care Company Shares by Value 2007-2011
  • Table 15 Adult Mouth Care Brand Shares by Value 2008-2011
  • Table 16 Forecast Sales of Adult Mouth Care: Value 2011-2016
  • Table 17 Forecast Sales of Adult Mouth Care: % Value Growth 2011-2016

Analgesics in Finland - Category Analysis

HEADLINES

TRENDS

  • Analgesics saw a modest 1% increase in current value terms in 2011, marginally slower than the year before. Analgesics is mature and saturation levels high. This prevents sales from growing more strongly. Another factor that limited growth in 2011 was the economic turbulence seen in the second half of the year, which made consumers more careful with their spending and decide to opt for cheaper products. Price competition is also intense in analgesics, which holds value growth rates back.

SWITCHES

COMPETITIVE LANDSCAPE

  • Orion is the leader in analgesics with a 45% value share in 2011. Its leading position is due to the company’s long presence in Finland and its popular and well-known Burana brand, which has become a household name. The company’s products enjoy prime shelf positioning, and benefit from nationwide distribution. Its portfolio also includes several formats, from tablets and effervescent to Paediatric formats, and also widely-known brands of topical analgesics/anaesthetics, such as Ketorin and Trombosol Forte. Finns trust the company’s brands, and have remained loyal to them over the years.

PROSPECTS

  • The analgesics environment is predicted to see a constant value CAGR of just 1% over the forecast period. The category is mature and price competition is predicted to increase, particularly as generics will be interesting options for consumers who feel the effects of the economic downturn. Sales of larger pack sizes, which retail at lower per unit prices, are also predicted to grow. This is likely to add pressure to brands which have higher unit prices.

CATEGORY DATA

  • Table 18 Sales of Analgesics by Category: Value 2006-2011
  • Table 19 Sales of Analgesics by Category: % Value Growth 2006-2011
  • Table 20 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2006-2011
  • Table 21 Analgesics Company Shares by Value 2007-2011
  • Table 22 Analgesics Brand Shares by Value 2008-2011
  • Table 23 Forecast Sales of Analgesics by Category: Value 2011-2016
  • Table 24 Forecast Sales of Analgesics by Category: % Value Growth 2011-2016

Calming and Sleeping in Finland - Category Analysis

HEADLINES

TRENDS

  • Calming and sleeping products increased by 3% in current value terms in 2011. Busy and hectic lifestyles provoked stress and sleeping problems, which encouraged consumers to look for ways to relax by using herbal calming and sleeping products in Finland. Awareness of these products continued to increase, bringing more customers to the category.

SWITCHES

COMPETITIVE LANDSCAPE

  • Domestic company Orion led calming and sleeping products with a 48% value share in 2011. Shares remained largely unchanged in 2011, with Ferrosan Oy growing the most, albeit only marginally. Over the review period Orion saw the best performance, gaining 37 percentage points compared with 2006.

PROSPECTS

  • Calming and sleeping products is predicted to increase by a constant value CAGR of 2% over the forecast period. Forecast sales will be stronger compared with the review period mainly as the occurrence of sleeping disorders is predicted to rise in Finland, triggered by increasing stress and irregular working hours.

CATEGORY DATA

  • Table 25 Sales of Calming and Sleeping: Value 2006-2011
  • Table 26 Sales of Calming and Sleeping: % Value Growth 2006-2011
  • Table 27 Calming and Sleeping Company Shares by Value 2007-2011
  • Table 28 Calming and Sleeping Brand Shares by Value 2008-2011
  • Table 29 Forecast Sales of Calming and Sleeping: Value 2011-2016
  • Table 30 Forecast Sales of Calming and Sleeping: % Value Growth 2011-2016

Cough, Cold and Allergy (Hay Fever) Remedies in Finland - Category Analysis

HEADLINES

TRENDS

  • Cough, cold and allergy remedies increased by 7% in current value terms in 2011. Seen over the review period current value sales grew by a healthy 24%. Switches of allergy remedies from Rx to OTC status particularly in 2009, 2010 and 2011 helped to push sales. The review period growth was also bolstered by a jump in sales in 2009 and 2010 as a result of the swine flu outbreak. Particularly cold winters towards the end of the review period also boosted sales.

SWITCHES

COMPETITIVE LANDSCAPE

  • Domestic player Orion led cough, cold and allergy (hay fever) remedies, holding a 19% value share in 2011. The company’s leadership is largely due to its solid position in cough remedies, in which it controls the three leading brands: Medipekt, Reodyn and Resilar. These brands are popular mainly because they have been available for a long time, and are thus well-known and trusted by most Finns. Moreover, Orion’s products have national coverage and hold prime shelf positioning.

PROSPECTS

  • Cough, cold and allergy (hay fever) remedies is predicted to see a 1% constant value CAGR over the forecast period. The rather modest growth is a result of increasing maturity and price competition from generics. However, less mature and more dynamic categories will continue to push sales, such as nasal decongestants. The increase of the sweet tax will increase prices on medicated confectionery and thus lead to higher growth.

CATEGORY DATA

  • Table 31 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
  • Table 32 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
  • Table 33 Sales of Decongestants by Category: Value 2006-2011
  • Table 34 Sales of Decongestants by Category: % Value Growth 2006-2011
  • Table 35 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2007-2011
  • Table 36 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2008-2011
  • Table 37 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2011-2016
  • Table 38 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2011-2016

Digestive Remedies in Finland - Category Analysis

HEADLINES

TRENDS

  • Digestive remedies increased by a healthy 6% in current value terms in 2011. Although dynamic this was slower than the vibrant development seen in 2010 when value sales grew by 8%. However, sales in 2011 were largely driven by the switch of proton pump inhibitors, a development that started in late 2009 and subsequently saw several products launched in 2010 and 2011, although the trend settled down.

SWITCHES

COMPETITIVE LANDSCAPE

  • Janssen-Cilag led digestive remedies with a 26% share of value sales in 2011. This position was primarily due to a large number of brands, such as Vi-Siblin, Pepcid, Imodium and Microlax, rather than one specific giant brand. The company, however, defended its lead by heavily advertising its Pepcid brand on national television.

PROSPECTS

  • Digestive remedies is expected to see a constant value CAGR of 2% over the forecast period. Growth will result from increasing awareness of digestive remedies, advertising, new product launches, the ageing population, growing stress levels and increasing obesity among the population. The more uncertain economic outlook has led to Euromonitor International revaluating the forecast constant value growth performance, slightly revising demand downwards compared with the previous year.

CATEGORY DATA

  • Table 39 Sales of Digestive Remedies by Category: Value 2006-2011
  • Table 40 Sales of Digestive Remedies by Category: % Value Growth 2006-2011
  • Table 41 Digestive Remedies Company Shares by Value 2007-2011
  • Table 42 Digestive Remedies Brand Shares by Value 2008-2011
  • Table 43 Forecast Sales of Digestive Remedies by Category: Value 2011-2016
  • Table 44 Forecast Sales of Digestive Remedies by Category: % Value Growth 2011-2016

Ear Care in Finland - Category Analysis

HEADLINES

TRENDS

  • Ear care saw a modest current value development in 2011, up only 3%. This was slightly stronger than the development in 2010 as well as the review period average. The increase of VAT on medicines from 8% to 9% in July 2010, boosted the category’s value in 2011.

SWITCHES

COMPETITIVE LANDSCAPE

  • Domestic company Orion retained its leading position in ear care with a 58% value share in 2011. This position was due to its Remo-Wax brand.

PROSPECTS

  • Ear care is predicted to see a marginal constant value CAGR over the forecast period. Due to the small product selection and slowly growing customer base, ear care in Finland is facing stagnation.

CATEGORY DATA

  • Table 45 Sales of Ear Care: Value 2006-2011
  • Table 46 Sales of Ear Care: % Value Growth 2006-2011
  • Table 47 Ear Care Company Shares by Value 2007-2011
  • Table 48 Ear Care Brand Shares by Value 2008-2011
  • Table 49 Forecast Sales of Ear Care: Value 2011-2016
  • Table 50 Forecast Sales of Ear Care: % Value Growth 2011-2016

Emergency Contraception in Finland - Category Analysis

HEADLINES

TRENDS

  • Emergency contraception increased by 3% in current value terms in 2011. Growing sales were the result of greater awareness of the availability of emergency contraception. Some of the 2011 increase was also a result of increased VAT on medicines from 8% to 9% in July 2010.

COMPETITIVE LANDSCAPE

  • Leiras Finland remained the only company present in emergency contraception, with a 100% share of value sales in 2011 with its NorLevo brand.

PROSPECTS

  • Emergency contraception is expected to see a constant value CAGR of well below 1% over the forecast period. The forecast period will see slightly slower constant value growth than the review period, mainly as growth will start to stagnate as the category becomes increasingly mature.

CATEGORY DATA

  • Table 51 Sales of Emergency Contraception: Value 2006-2011
  • Table 52 Sales of Emergency Contraception: % Value Growth 2006-2011
  • Table 53 Emergency Contraception Company Shares by Value 2007-2011
  • Table 54 Emergency Contraception Brand Shares by Value 2008-2011
  • Table 55 Forecast Sales of Emergency Contraception: Value 2011-2016
  • Table 56 Forecast Sales of Emergency Contraception: % Value Growth 2011-2016

Eye Care in Finland - Category Analysis

HEADLINES

TRENDS

  • Eye care increased by 2% in current value terms in 2011, almost identically with the previous year. Growing sales were due to the increasing occurrence of dry eye symptoms and allergies. The ageing population and growing use of contact lenses, as well as computers, also contributed to growth.

SWITCHES

COMPETITIVE LANDSCAPE

  • Santen Oy led eye care in 2011 with a 32% value share, down marginally compared with 2006. Santen’s lead was a result of its popular Lecrolyn and Oftagel brands, but the company also has a number of other smaller brands in its portfolio, such as Oftan and Artelac. These brands offer a good selection of products, which are also well advertised and benefit from good nationwide distribution.

PROSPECTS

  • Eye care is predicted to see a marginal constant value CAGR over the forecast period. The category is no longer young or dynamic, and therefore growth rates will be modest. However, sales will see slightly stronger growth than that seen over the review period, mainly as the occurrence of problems with dry eyes is predicted to grow and as the ageing population will drive growth above levels seen over the review period.

CATEGORY DATA

  • Table 57 Sales of Eye Care by Category: Value 2006-2011
  • Table 58 Sales of Eye Care by Category: % Value Growth 2006-2011
  • Table 59 Standard Eye Care by Format: % Value Breakdown 2007-2011
  • Table 60 Standard Eye Care by Positioning: % Value Breakdown 2007-2011
  • Table 61 Eye Care Company Shares by Value 2007-2011
  • Table 62 Eye Care Brand Shares by Value 2008-2011
  • Table 63 Forecast Sales of Eye Care by Category: Value 2011-2016
  • Table 64 Forecast Sales of Eye Care by Category: % Value Growth 2011-2016

Herbal/Traditional Products in Finland - Category Analysis

HEADLINES

TRENDS

  • Herbal/traditional products saw 3% current value growth in 2011. Growth in 2011 was slightly better than the review period CAGR, mainly as sales recovered strongly during the first half of 2011. However, towards the second half of 2011 sales slowed down somewhat as consumers became more negative regarding the future economic situation in the country and globally.

COMPETITIVE LANDSCAPE

  • The herbal/traditional products environment is fragmented, with a large number of players present. International companies dominated the category in 2011 with their famous strong brands. Procter & Gamble Finland remained in the leading player in 2011 with a 12% value share. This position is due to its popular Vicks brand in herbal/traditional cough, cold and allergy (hay fever) remedies, which is the second-most important category. Vicks benefits from being widely available in the grocery retail channel, and the fact that it has been on the market for a long time.

PROSPECTS

  • The herbal/traditional products category is predicted to see a constant value CAGR of around 1% over the forecast period. Maturity and the forecast economic downturn will undermine value sales. Price competition will remain intense.

CATEGORY DATA

  • Table 65 Sales of Herbal/Traditional Products: Value 2006-2011
  • Table 66 Sales of Herbal/Traditional Products: % Value Growth 2006-2011
  • Table 67 Herbal/Traditional Products Company Shares 2007-2011
  • Table 68 Herbal/Traditional Products Brand Shares 2008-2011
  • Table 69 Forecast Sales of Herbal/Traditional Products: Value 2011-2016
  • Table 70 Forecast Sales of Herbal/Traditional Products: % Value Growth 2011-2016

Medicated Skin Care in Finland - Category Analysis

HEADLINES

TRENDS

  • Medicated skin care increased by 2% in current value terms in 2011, representing a slight recovery after the economic recession that started in late 2008. In the second half of 2011, however, it seemed as if consumers started to buy cheaper products again following the gloomier outlook for the Finnish economy.

SWITCHES

COMPETITIVE LANDSCAPE

  • The domestic company Orion maintained its lead in medicated skin care in 2011, holding a 35% share of value sales. This position was a result of Orion’s strong position in the large antipruritics and antifungals categories. Orion is one of the only domestic companies present in medicated skin care.

PROSPECTS

  • Medicated skin care is predicted to see a negligible positive constant value CAGR over the forecast period. The category is already mature, and companies will have to deal with saturation. Also, competition in many categories is harsh due to a wide selection of strong brands. Generic products are expected to continue to interest consumers due to their lower prices.

CATEGORY DATA

  • Table 71 Sales of Medicated Skin Care by Category: Value 2006-2011
  • Table 72 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
  • Table 73 Medicated Skin Care Company Shares by Value 2007-2011
  • Table 74 Medicated Skin Care Brand Shares by Value 2008-2011
  • Table 75 Hair Loss Treatments Brand Shares by Value 2008-2011
  • Table 76 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
  • Table 77 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016

NRT Smoking Cessation Aids in Finland - Category Analysis

HEADLINES

TRENDS

  • NRT smoking cessation aids increased by 6% in current value terms in 2011. New launches and growing sales through the grocery channel fuelled sales in 2011. Nicorette, for example, entered the NRT lozenges niche in late 2010, adding value to the category.

SWITCHES

COMPETITIVE LANDSCAPE

  • Janssen-Cilag strengthened its leading position in NRT smoking cessation aids to 53% in 2011. The company’s value share was up by almost one percentage point in 2011, boosted by the entry of the Nicorette brand in NRT lozenges.

PROSPECTS

  • NRT smoking cessation aids is predicted to increase by a CAGR of 3% over the forecast period. The forecast growth is far slower compared with the healthy 7% constant value CAGR seen over the review period. The category has grown strongly over the last decade and sales have settled down. The environment is more mature and the effects of liberalised distribution have faded.

CATEGORY INDICATORS

  • Table 78 Number of Smokers by Gender 2006-2011

CATEGORY DATA

  • Table 79 Sales of NRT Smoking Cessation Aids by Category: Value 2006-2011
  • Table 80 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2006-2011
  • Table 81 NRT Gum Flavours: % Value Breakdown 2006-2011
  • Table 82 NRT Smoking Cessation Aids Company Shares by Value 2007-2011
  • Table 83 NRT Smoking Cessation Aids Brand Shares by Value 2008-2011
  • Table 84 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2011-2016
  • Table 85 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2011-2016

Sports Nutrition in Finland - Category Analysis

HEADLINES

TRENDS

  • Sports nutrition increased by almost 5% in current value terms in 2011. Sales were driven not only by the growing fitness culture in Finland, but also by advertising and growing sales of sports nutrition products through the grocery channel. However, sales slowed down in the second half of 2011 due to the economic turbulence.

COMPETITIVE LANDSCAPE

  • Func Food Finland Oy (previously Scandic Research Oy) held the leading position in sports nutrition, accounting for 28% of value sales in 2011. This position was due to the Fast brand, which is present in a variety of different types in most sports nutrition categories. The large product portfolio, with products widely available in most channels including grocery outlets, supported the company’s leading position. Func Food Finland also issues “Gym” magazine, which further supported sales of the company’s brands. Its products also enjoy an excellent distribution network and have prime shelf positioning.

PROSPECTS

  • Sports nutrition is expected to see a constant value CAGR of 2% over the forecast period. Sales will be driven by a growing proportion of the general public being interested in body building and more serious sports.

CATEGORY DATA

  • Table 86 Sales of Sports Nutrition: Value 2006-2011
  • Table 87 Sales of Sports Nutrition: % Value Growth 2006-2011
  • Table 88 Sports Nutrition Company Shares 2007-2011
  • Table 89 Sports Nutrition Brand Shares 2008-2011
  • Table 90 Forecast Sales of Sports Nutrition: Value 2011-2016
  • Table 91 Forecast Sales of Sports Nutrition: % Value Growth 2011-2016

Vitamins and Dietary Supplements in Finland - Category Analysis

HEADLINES

TRENDS

  • Vitamins and dietary supplements saw a rather healthy 4% current value growth in 2011. Growing sales were underpinned by a strong health trend in Finland, with an increasing number of consumers interested in preventative medicine and product category. Product launches and supporting advertising campaigns added further impetus to growth. A small part of the market value increase in 2011 was also a result of increased VAT on medicines from 8% to 9% in July 2010.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • The vitamins and dietary supplements environment is fragmented in Finland, with a very wide choice of products available, most of which are niche offerings. International brands hold the largest individual shares in vitamins and dietary supplements, but local companies are also strongly present.

PROSPECTS

  • Vitamins and dietary supplements is predicted to see a constant value CAGR of 2% over the forecast period. The category is rather mature although some categories are still underdeveloped. The predicted economic downturn and increasing price competition will also prevent sales from growing more strongly. Due to the more pessimistic economic outlook forecast constant value growth has been revised downwards compared with the previous edition of this report.

CATEGORY DATA

  • Summary 18 Dietary Supplements: Brand Ranking by Positioning 2011
  • Table 92 Sales of Vitamins and Dietary Supplements by Category: Value 2006-2011
  • Table 93 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2006-2011
  • Table 94 Dietary Supplements by Positioning 2006-2011
  • Table 95 Vitamins and Dietary Supplements Company Shares by Value 2007-2011
  • Table 96 Vitamins and Dietary Supplements Brand Shares by Value 2008-2011
  • Table 97 Vitamins Brand Shares by Value 2008-2011
  • Table 98 Dietary Supplements Brand Shares by Value 2008-2011
  • Table 99 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2011-2016
  • Table 100 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2011-2016

Weight Management in Finland - Category Analysis

HEADLINES

TRENDS

  • Weight management increased by 4% in current value terms in 2011. Growth was due to increased demand following rising obesity levels, and as consumers have become more worried about their well-being and appearance. Advertising was also significant in this category. Finally, good availability, including the grocery retailing channel, also benefited sales.

COMPETITIVE LANDSCAPE

  • Axellus led weight management in 2011 with a 17% value share. Axellus saw an increase of approaching one percentage point compared with the previous year. The company’s position is mainly due to its strength in the meal replacement slimming category, in which its popular and well-known Nutrilett brand is doing very well.

PROSPECTS

  • Weight management is predicted to increase by a constant value CAGR of 1% over the forecast period. This is far lower than the review period CAGR of 6%. The forecast economic downturn and increasing maturity will prevent sales from achieving higher levels. Also, the strongly growing sales in OTC obesity has settled down and will thus not act as an engine for weight management growth as seen over the review period.

CATEGORY DATA

  • Table 101 Sales of Weight Management: Value 2006-2011
  • Table 102 Sales of Weight Management: % Value Growth 2006-2011
  • Table 103 Weight Management Company Shares 2007-2011
  • Table 104 Weight Management Brand Shares 2008-2011
  • Table 105 Forecast Sales of Weight Management: Value 2011-2016
  • Table 106 Forecast Sales of Weight Management: % Value Growth 2011-2016

Wound Care in Finland - Category Analysis

HEADLINES

TRENDS

  • Wound care increased by 3% in current value terms in 2011. Sales also accelerated slightly over the last two years as demand picked up after the recession, which saw consumers cut down on purchases or trade down to cheaper brands.

COMPETITIVE LANDSCAPE

  • Cederroth led wound care in 2011 taking a 36% value share. Its lead is due to the well-known and trusted Salvequick brand. Salvequick has a wide portfolio of products which is often extended with new launches. Salvequick products are widely available through most distribution channels.

PROSPECTS

  • Wound care is predicted to see a marginal constant value CAGR over the forecast period. The rather low level of growth is a result of maturity and already high penetration. However, the forecast growth will be slightly better than that seen over the review period, mainly as competition from private label products settles down, and as branded operators are believed to focus on introducing more advanced goods.

CATEGORY DATA

  • Table 107 Sales of Wound Care by Category: Value 2006-2011
  • Table 108 Sales of Wound Care by Category: % Value Growth 2006-2011
  • Table 109 Wound Care Company Shares by Value 2007-2011
  • Table 110 Wound Care Brand Shares by Value 2008-2011
  • Table 111 Forecast Sales of Wound Care by Category: Value 2011-2016
  • Table 112 Forecast Sales of Wound Care by Category: % Value Growth 2011-2016

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Paediatric Analgesics
            • Paediatric Acetaminophen
            • Paediatric Aspirin
            • Paediatric Combination Products - Analgesics
            • Paediatric Diclofenac
            • Paediatric Dipyrone
            • Paediatric Ibuprofen
            • Paediatric Ketoprofen
            • Paediatric Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Paediatric Cough, Cold and Allergy Remedies
          • Paediatric Allergy Remedies
          • Paediatric Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Paediatric Digestive Remedies
          • Paediatric Diarrhoeal Remedies
          • Paediatric Indigestion and Heartburn Remedies
          • Paediatric Laxatives
          • Paediatric Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Paediatric Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
      • Protein Products
        • Bars
        • Powder
        • RTD
        • Other Protein
      • Non-Protein Products
    • Vitamins and Dietary Supplements
      • Paediatric Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
            • Cranberry
            • Spirulina
            • Other Other Herbal/Traditional Dietary Supplements
        • Non-Herbal Dietary Supplements
          • Calcium Supplements
          • Co-Enzyme Q10
          • Combination Non-Herbal Dietary Supplements
          • Eye Health Supplements
          • Fish Oils
            • Cod Liver Oil
            • Other Fish Oils
          • Glucosamine
          • Mineral Supplements
          • Omega-3-6-9 (Fish and Non-Fish)
          • Probiotic Supplements
          • Protein Powder
          • Royal Jelly
          • Sam-E
          • Other Non-Herbal Dietary Supplements
            • Benecol
            • Lecithin
            • Other Other Non-Herbal Dietary Supplements
      • Tonics and Bottled Nutritive Drinks
      • Vitamins
        • Multivitamins
        • Single Vitamins
          • Vitamin A
          • Vitamin B
          • Vitamin C
          • Vitamin D
          • Vitamin E
          • Other Single Vitamins
    • Weight Management
      • Meal Replacement Slimming
      • OTC Obesity
      • Slimming Teas
      • Weight Loss Supplements
      • Other Slimming Products
    • Herbal/Traditional Products
      • Herbal/Traditional Analgesics
      • Herbal/Traditional Calming and Sleeping Products
      • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
      • Herbal/Traditional Digestive Remedies
      • Herbal/Traditional Medicated Skin Care
      • Herbal/Traditional Medicinal Teas
      • Herbal/Traditional Smoking Cessation Aids
      • Herbal/Traditional Paediatric Dietary Supplements
      • Herbal/Traditional Dietary Supplements
      • Herbal/Traditional Tonics and Bottled Nutritive Drinks
    • Allergy Care
      • Allergy Eye Care
      • Antihistamines/Allergy Remedies (Systemic)
      • Paediatric Allergy Remedies
      • Topical Allergy Remedies/Antihistamines
    • Paediatric Consumer Health
      • Paediatric Analgesics
        • Paediatric Acetaminophen
        • Paediatric Aspirin
        • Paediatric Combination Products - Analgesics
        • Paediatric Diclofenac
        • Paediatric Dipyrone
        • Paediatric Ibuprofen
        • Paediatric Ketoprofen
        • Paediatric Naproxen
      • Paediatric Cough, Cold and Allergy Remedies
        • Paediatric Allergy Remedies
        • Paediatric Cough/Cold Remedies
      • Paediatric Digestive Remedies
        • Paediatric Diarrhoeal Remedies
        • Paediatric Indigestion and Heartburn Remedies
        • Paediatric Laxatives
        • Paediatric Motion Sickness Remedies
      • Paediatric Medicated Skin Care
      • Nappy (Diaper) Rash Treatments
      • Paediatric Vitamins and Dietary Supplements

Statistics Included

Statistics Included

For each category and subcategory you will receive the following data in Excel format:

From Passport

  • Market sizes
  • Company shares
  • Brand shares
  • Distribution
  • Analysis by format
  • Analysis by positioning
  • Analysis by type
  • Herbal/traditional vs standard
  • Pricing
  • Smoking population - number of adult smokers
  • Smoking prevalence - % of adult population

Market size details:

  • Retail volume
  • Retail volume % growth
  • Retail volume per capita
  • Retail value retail selling price % growth
  • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price % growth
  • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY

Methodology

Methodology

Global insight and local knowledge

With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

Industry specialists

Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

Country and regional analysts

Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

In-country research network

To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

Research Methodology

Our research methods

Each Euromonitor International industry report is based on a core set of research techniques:

Desk research

With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

  • National statistics offices governmental and official sources
  • National and international trade press
  • National and international trade associations
  • Industry study groups and other semi-official sources
  • Company financials and annual reports
  • Broker reports
  • Online databases
  • The financial, business and mainstream press

Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

Store checks

Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

  • Place: We track products in all relevant channels, selective and mass, store and non-store
  • Product: What are innovations in products, pack sizes and formats?
  • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
  • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

Trade survey

Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

Trade surveys allow us to:

  • Fill gaps in available published data per company
  • Generate a consensus view of the size, structure and strategic direction of the category
  • Access year-in-progress data where published sources are out of date
  • Evaluate the experts’ views on current trends and market developments

In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

Company analysis

At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

Forecasts

Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

Data validation

All data is subjected to an exhaustive review process, at country, regional and global levels.

The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

Market analysis

Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

my pages

Want to find out more about this report?

If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!